These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22510874)

  • 41. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
    Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CEBPE expression is an independent prognostic factor for acute myeloid leukemia.
    Li K; Du Y; Wei DQ; Zhang F
    J Transl Med; 2019 Jun; 17(1):188. PubMed ID: 31164135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of osteopontin in acute myeloid leukemia: A meta-analysis.
    Chen YB; Ren SM; Li SD; Du Z
    Mol Clin Oncol; 2017 Aug; 7(2):275-280. PubMed ID: 28781801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
    Bertoli S; Paubelle E; Bérard E; Saland E; Thomas X; Tavitian S; Larcher MV; Vergez F; Delabesse E; Sarry A; Huguet F; Larrue C; Bosc C; Farge T; Sarry JE; Michallet M; Récher C
    Eur J Haematol; 2019 Feb; 102(2):131-142. PubMed ID: 30325535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML.
    Abdelhafiz AS; Elsayed GM; Saber MM; Gameel A; Hamdy N
    Int J Lab Hematol; 2020 Jun; 42(3):263-269. PubMed ID: 32048789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells.
    Zahed Panah M; Nikbakht M; Sajjadi SM; Rostami S; Norooznezhad AH; Kamranzadeh Fumani H; Ghavamzadeh A; Mohammadi S
    Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):148-157. PubMed ID: 28875010
    [No Abstract]   [Full Text] [Related]  

  • 50. Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia.
    Xiang Y; Zhou X
    Hematology; 2018 Dec; 23(10):721-728. PubMed ID: 29950146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
    Thol F; Winschel C; Sonntag AK; Damm F; Wagner K; Chaturvedi A; Göhring G; Schlegelberger B; Lübbert M; Fiedler W; Kirchner H; Krauter J; Ganser A; Heuser M
    Ann Hematol; 2013 Mar; 92(3):315-23. PubMed ID: 23233047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia.
    Zhang J; Ma D; Ye J; Zang S; Lu F; Yang M; Qu X; Sun X; Ji C
    Oncol Rep; 2012 Oct; 28(4):1503-11. PubMed ID: 22858860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125.
    Wang YH; Lin CC; Hsu CL; Hung SY; Yao CY; Lee SH; Tsai CH; Hou HA; Chou WC; Tien HF
    Ann Hematol; 2021 Feb; 100(2):487-498. PubMed ID: 33225420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
    Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
    J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.
    Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT
    Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic relevance of CD123 expression in adult AML with normal karyotype.
    Jiang G; Atenafu EG; Capo-Chichi JM; Minden MD; Chang H
    Br J Haematol; 2020 Jan; 188(1):181-184. PubMed ID: 31758553
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Harada K; Konuma T; Machida S; Mori J; Aoki J; Uchida N; Ohashi K; Fukuda T; Tanaka M; Ikegame K; Ozawa Y; Iwato K; Eto T; Onizuka M; Ichinohe T; Atsuta Y; Yano S
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1730-1743. PubMed ID: 31054982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
    Deng A; Ning Q; Zhou L; Liang Y
    Sci Rep; 2016 Jun; 6():27694. PubMed ID: 27291931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.